vs
Side-by-side financial comparison of HARROW, INC. (HROW) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $89.1M, roughly 1.0× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs 3.2%, a 4.2% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -1.5%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $2.9M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 3.8%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
HROW vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $93.5M |
| Net Profit | $6.6M | $3.0M |
| Gross Margin | 79.3% | 41.0% |
| Operating Margin | 17.5% | 7.0% |
| Net Margin | 7.4% | 3.2% |
| Revenue YoY | 33.3% | -1.5% |
| Net Profit YoY | -2.2% | -3.7% |
| EPS (diluted) | $0.20 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $93.5M | ||
| Q3 25 | $71.6M | $88.9M | ||
| Q2 25 | $63.7M | $89.4M | ||
| Q1 25 | $47.8M | $85.7M | ||
| Q4 24 | $66.8M | $94.9M | ||
| Q3 24 | $49.3M | $88.5M | ||
| Q2 24 | $48.9M | $85.8M | ||
| Q1 24 | $34.6M | $86.8M |
| Q4 25 | $6.6M | $3.0M | ||
| Q3 25 | $1.0M | $453.0K | ||
| Q2 25 | $5.0M | $-9.5M | ||
| Q1 25 | $-17.8M | $-4.0M | ||
| Q4 24 | $6.8M | $3.1M | ||
| Q3 24 | $-4.2M | $-60.6M | ||
| Q2 24 | $-6.5M | $-1.7M | ||
| Q1 24 | $-13.6M | $-1.1M |
| Q4 25 | 79.3% | 41.0% | ||
| Q3 25 | 75.3% | 40.6% | ||
| Q2 25 | 74.5% | 40.6% | ||
| Q1 25 | 67.5% | 39.6% | ||
| Q4 24 | 78.8% | 42.4% | ||
| Q3 24 | 75.6% | 41.2% | ||
| Q2 24 | 74.4% | 39.5% | ||
| Q1 24 | 69.5% | 42.3% |
| Q4 25 | 17.5% | 7.0% | ||
| Q3 25 | 20.6% | 1.9% | ||
| Q2 25 | 17.9% | -1.9% | ||
| Q1 25 | -23.5% | -2.4% | ||
| Q4 24 | 19.3% | 4.1% | ||
| Q3 24 | 2.7% | -67.4% | ||
| Q2 24 | 3.1% | -2.2% | ||
| Q1 24 | -20.0% | -2.2% |
| Q4 25 | 7.4% | 3.2% | ||
| Q3 25 | 1.4% | 0.5% | ||
| Q2 25 | 7.8% | -10.6% | ||
| Q1 25 | -37.2% | -4.7% | ||
| Q4 24 | 10.1% | 3.3% | ||
| Q3 24 | -8.6% | -68.5% | ||
| Q2 24 | -13.2% | -2.0% | ||
| Q1 24 | -39.2% | -1.2% |
| Q4 25 | $0.20 | $9.50 | ||
| Q3 25 | $0.03 | $-0.86 | ||
| Q2 25 | $0.13 | $-2.73 | ||
| Q1 25 | $-0.50 | $-1.66 | ||
| Q4 24 | $0.19 | $-0.47 | ||
| Q3 24 | $-0.12 | $-12.79 | ||
| Q2 24 | $-0.18 | $-1.19 | ||
| Q1 24 | $-0.38 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $23.6M |
| Total DebtLower is stronger | $250.0M | $41.5M |
| Stockholders' EquityBook value | $52.4M | $111.4M |
| Total Assets | $399.5M | $407.7M |
| Debt / EquityLower = less leverage | 4.77× | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $23.6M | ||
| Q3 25 | $74.3M | $26.7M | ||
| Q2 25 | $53.0M | $26.0M | ||
| Q1 25 | $66.7M | $31.0M | ||
| Q4 24 | $47.2M | $29.9M | ||
| Q3 24 | $72.6M | $20.0M | ||
| Q2 24 | $71.0M | $14.7M | ||
| Q1 24 | $76.0M | $18.7M |
| Q4 25 | $250.0M | $41.5M | ||
| Q3 25 | $347.2M | $41.4M | ||
| Q2 25 | $250.6M | $41.3M | ||
| Q1 25 | $256.9M | $41.3M | ||
| Q4 24 | $262.7M | $41.2M | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
| Q4 25 | $52.4M | $111.4M | ||
| Q3 25 | $47.0M | $-26.3M | ||
| Q2 25 | $49.7M | $-21.7M | ||
| Q1 25 | $56.5M | $-13.5M | ||
| Q4 24 | $69.7M | $-8.3M | ||
| Q3 24 | $58.0M | $-2.7M | ||
| Q2 24 | $58.5M | $45.8M | ||
| Q1 24 | $60.6M | $51.4M |
| Q4 25 | $399.5M | $407.7M | ||
| Q3 25 | $363.1M | $406.9M | ||
| Q2 25 | $345.0M | $415.9M | ||
| Q1 25 | $364.2M | $421.5M | ||
| Q4 24 | $389.0M | $430.2M | ||
| Q3 24 | $351.5M | $412.5M | ||
| Q2 24 | $306.6M | $474.1M | ||
| Q1 24 | $295.5M | $477.7M |
| Q4 25 | 4.77× | 0.37× | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $3.2M |
| Free Cash FlowOCF − Capex | $8.1M | $2.9M |
| FCF MarginFCF / Revenue | 9.1% | 3.1% |
| Capex IntensityCapex / Revenue | 0.4% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.27× | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $3.2M | ||
| Q3 25 | $16.6M | $9.5M | ||
| Q2 25 | $-803.0K | $932.0K | ||
| Q1 25 | $19.7M | $9.1M | ||
| Q4 24 | $-17.8M | $-10.0M | ||
| Q3 24 | $3.0M | $12.5M | ||
| Q2 24 | $-2.7M | $8.7M | ||
| Q1 24 | $-4.6M | $6.9M |
| Q4 25 | $8.1M | $2.9M | ||
| Q3 25 | $16.4M | $9.4M | ||
| Q2 25 | $-969.0K | $787.0K | ||
| Q1 25 | $19.5M | $8.7M | ||
| Q4 24 | $-18.3M | $-10.3M | ||
| Q3 24 | $2.3M | $12.4M | ||
| Q2 24 | $-3.1M | $8.5M | ||
| Q1 24 | $-4.7M | $6.6M |
| Q4 25 | 9.1% | 3.1% | ||
| Q3 25 | 22.9% | 10.5% | ||
| Q2 25 | -1.5% | 0.9% | ||
| Q1 25 | 40.8% | 10.1% | ||
| Q4 24 | -27.4% | -10.8% | ||
| Q3 24 | 4.8% | 14.0% | ||
| Q2 24 | -6.3% | 10.0% | ||
| Q1 24 | -13.6% | 7.6% |
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.3% | 0.2% | ||
| Q1 25 | 0.4% | 0.4% | ||
| Q4 24 | 0.8% | 0.2% | ||
| Q3 24 | 1.2% | 0.1% | ||
| Q2 24 | 0.7% | 0.2% | ||
| Q1 24 | 0.3% | 0.3% |
| Q4 25 | 1.27× | 1.07× | ||
| Q3 25 | 16.26× | 20.96× | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.62× | -3.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
